Full dossier in preparation
Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.
Process with priority
Sign in free to move this company to the front.
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of BERYVE is 0.2% (very low). The 2024 annual accounts show negative equity (€-205k) and a net result of €4k. Its solvency ranks better than 5% of 6548 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.2%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Annual accounts: weaker financial profile
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Trust signals
3 signalsMore than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€4k
Working capital€-301k-57.2%
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 04-07-2025 with the NBB · fiscal year 2024 · micro
Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -9.2% | 66.7% | |
| Net result | €4k | €46k | |
| Equity | €-205k | €79k | |
| Gross operating margin | €300k | €79k | |
| Staff costs | €148k | €21k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€149k
-
+224% vs sector
€4k
-
-59% vs sector
€96k
-
+149% vs sector
€2.22M
+3.6%
+286% vs sector
€-205k
+1.9%
far below sector median
€-301k
-57.2%
far below sector median
3
+150.0%
+100% vs sector
€148k
+108.3%
+179% vs sector
€2.43M
+3.1%
far above sector median
€508k
+32.8%
far above sector median
€1.92M
-2.6%
far above sector median
0.41
-18.4%
-90% vs sector
0.31
-22.9%
-92% vs sector
-9.2%
+5.3%
far below sector median
-11.83
-5.1%
far below sector median
-1.9%
-
far below sector median
0.2%
-
-89% vs sector
2.83
-
-89% vs sector
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €149k |
| Net profit | €4k |
| Cash flow | €96k |
| Staff costs | €148k |
| Income taxes | - |
| Dividends | - |
| Total assets | €2.22M |
| Equity | €-205k |
| Debt | €2.43M |
| of which ≤ 1y | €508k |
| of which > 1y | €1.92M |
| Working capital | €-301k |
| Employees (FTE) | 3.0 |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.41 |
| Quick ratio | 0.31 |
| Working capital ratio | -13.5% |
| Solvency | -9.2% |
| Debt / equity | -11.83 |
| Long-term debt ratio | -9.35 |
| Interest coverage | 2.83 |
| Gross margin | - |
| Net margin | - |
| ROA | 0.2% |
| ROE | -1.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.22M |
| Fixed assets | 21/28 | €2.01M |
| Tangible fixed assets | 22/27 | €2.01M |
| Current assets | 29/58 | €208k |
| Stocks & contracts in progress | 3 | €48k |
| Amounts receivable within one year | 40/41 | €133k |
| Cash & bank | 54/58 | €18k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.22M |
| Equity | 10/15 | €-205k |
| Contributions / capital | 10/11 | €51k |
| Accumulated profits (losses) | 14 | €-256k |
| Amounts payable | 17/49 | €2.43M |
| Amounts payable after one year | 17 | €1.92M |
| Amounts payable within one year | 42/48 | €508k |
| Trade debts payable within one year | 44 | €65k |
| Income statement | ||
| Gross operating margin | 9900 | €300k |
| Operating result | 9901 | €56k |
| Financial income | 75 | €7 |
| Financial charges | 65 | €53k |
| Result before taxes | 9903 | €4k |
| Net result for the period | 9904 | €4k |
| Result to be appropriated | 9905 | €4k |
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computed11
/ 100
Critical
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.
Structure & network
Locations & real estate
Registered office
on the map · from the address register
seat.Municipality
exact location from the address register
Establishment units
1 locationEngage Clinic
since 20222.333.326.981
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area3,518 m²
Buildings1
Building footprint779 m²
Volume (LiDAR)25 m³
Tallest building10.6 m
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71328D3269/00A000 | Flanders | 3,518 m² | 1 · 779 m² | 10.6 m |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Analysis
Snowflake analysis
financial profile on 5 axes43
/ 100
Fragile profile, watch profitability in particular.
Health
11
Profitability
0
Solvency
33
Growth
78
Stability
94
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, nearest firstCompany registry
Company registry (CBE)
Crossroads BankActivities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
| Legal nameNL | BERYVE |
Registered office
Luikersteenweg 328C bus 0.01
3500 Hasselt, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.